An affected pedigree member analysis of linkage between the dopamine D2 receptor gene TaqI polymorphism and obesity and hypertension

被引:35
作者
Fang, YJ
Thomas, GN
Xu, ZL
Fang, JQ
Critchley, AJH
Tomlinson, B
机构
[1] Univ Hong Kong, Dept Community Med, Hong Kong, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China
[3] Sun Yat Sen Univ Med Sci, Dept Med Stat, Guangzhou, Peoples R China
关键词
affected pedigree member sib-pair analysis; metabolic syndrome; central obesity; dopamine D2 receptor gene; hypertension;
D O I
10.1016/j.ijcard.2004.05.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Dopamine modulates a variety of physiological functions including natriuresis and satiety. We have previously reported that the TaqI polymorphism of the dopamine D2 receptor (DD2R) gene is associated with both blood pressure and obesity indices in a normoglycaemic Hong Kong Chinese population. In this study, we present evidence confirming the linkage between this gene polymorphism, obesity and hypertension. Methods: Two hundred and seventy-four siblings from 96 normoglycaemic hypertensive families were recruited, including 133 who were hypertensive. Central obesity was defined as a waist-to-hip ratio of >= 0.9 and >= 0.85 in males and females, respectively, and was identified in 99 of the siblings. The DD2R gene TaqI polymorphism was identified with a polymerase chain reaction based restriction fragment length polymorphism protocol. The affected pedigree member (APM) linkage analysis (sib-pair program, version 0.99.9, by D.L. Duffy) was used to assess for linkage between this gene polymorphism, obesity and hypertension in 73 families with siblings discordant for hypertension. Results: The At allele frequencies were similar in the 133 hypertensive, and 141 normotensive siblings, including the 99 centrally obese siblings at 0.431. 0.421 and 0.418, respectively. APM linkage analysis suggested that the DD2R gene TaqI polymorphism had evidence of linkage with blood pressure (T=-1.86, P=0.013), as well as with obesity (T=-1.58, P=0.007). Conclusion: Our data in normoglycaemic Hong Kong Chinese supports that the DD2R gene TaqI polymorphism is a marker associated with the pathogenesis of obesity and hypertension. (c) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:111 / 116
页数:6
相关论文
共 39 条
[1]   Factor analysis of the metabolic syndrome:: obesity vs insulin resistance as the central abnormality [J].
Anderson, PJ ;
Critchley, JAJH ;
Chan, JCN ;
Cockram, CS ;
Lee, ZSK ;
Thomas, GN ;
Tomlinson, B .
INTERNATIONAL JOURNAL OF OBESITY, 2001, 25 (12) :1782-1788
[2]   LONG-TERM ADMINISTRATION OF SOME ANTIPSYCHOTIC-DRUGS INCREASES BODY-WEIGHT AND FEEDING IN RATS - ARE D2 DOPAMINE-RECEPTORS INVOLVED [J].
BAPTISTA, T ;
PARADA, M ;
HERNANDEZ, L .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1987, 27 (03) :399-405
[3]  
Bek MJ, 2001, MT SINAI J MED, V68, P362
[4]   Increased prevalence of the Taq I A(1) allele of the dopamine receptor gene (DRD(2)) in obesity with comorbid substance use disorder: A preliminary report [J].
Blum, K ;
Braverman, ER ;
Wood, RC ;
Gill, J ;
Li, C ;
Chen, TJH ;
Taub, M ;
Montgomery, AR ;
Sheridan, PJ ;
Cull, JG .
PHARMACOGENETICS, 1996, 6 (04) :297-305
[5]   Renal dopamine system - Paracrine regulator of sodium homeostasis and blood pressure [J].
Carey, RM .
HYPERTENSION, 2001, 38 (03) :297-302
[6]  
CIVELLI O, 1993, ANNU REV PHARMACOL, V33, P281, DOI 10.1146/annurev.pa.33.040193.001433
[7]   THE DOPAMINE-D(2) RECEPTOR (DRD2) AS A MAJOR GENE IN OBESITY AND HEIGHT [J].
COMINGS, DE ;
FLANAGAN, SD ;
DIETZ, G ;
MUHLEMAN, D ;
KNELL, E ;
GYSIN, R .
BIOCHEMICAL MEDICINE AND METABOLIC BIOLOGY, 1993, 50 (02) :176-185
[8]  
Comings DE, 1996, MOL PSYCHIATR, V1, P325
[9]  
DOSS FW, 1979, J CLIN PSYCHIAT, V40, P528
[10]  
DUFFY DL, 2000, SIB PAIR PROGRAM ELE